ROSEMARY MAZANET

CIK 1276892 · Chief Scientific Officer · last filed 2025-04-07

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

37

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Oncternal Therapeutics, Inc. (ONCT) Delisted Director $0.53 $0 6 2024-06-24
SELLAS Life Sciences Group, Inc. (GALE) Delisted Chief Medical Officer $0 2 2013-01-31
Oncternal Therapeutics, Inc. (GTXI) Delisted Director 22,781 $0 12 2009-05-11

Recent Filings · Page 4 of 4

37 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2008-01-02 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) +505 $7.2K EDGAR
2007-10-02 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) +445 $7.3K EDGAR
2007-07-02 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) +308 $5.0K EDGAR
2007-05-07 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) $0 EDGAR
2007-04-03 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) +245 $5.0K EDGAR
2007-01-08 Grant (A) $0
2007-01-03 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) +280 $5.0K EDGAR
Showing 3137 of 37
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.